Significant Ownership of M.D. Ph.D. David D. Chang

Location
South San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by M.D. Ph.D. David D. Chang.

Notify me when M.D. Ph.D. David D. Chang files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of M.D. Ph.D. David D. Chang

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLO Allogene Therapeutics, Inc. Common Stock 5.2% $16,578,676 +$1,186,838 12,101,223 +7.7% David D. Chang, M.D., Ph.D. 31 Dec 2025

Schedules 13D/G Reported by M.D. Ph.D. David D. Chang:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.